A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial. Issue 12 (December 2018) - Burnett, A; Hills, R; Nielsen, O; Freeman, S; Ali, A; Cahalin, P; Hunter, A; Thomas, I; Russell, N